Open original FDA record ↗Recall record
- FDA identifier
- Z-0955-05
- Company in FDA record
- Boston Scientific CRM Corp
- FDA classification date
- Jun 30, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The atrial therapy (AVT) subgroups of certain Guidant ICD and CRT-D product families are subject to a condition in which a random memory error causes functional 'latching' that limits available therapy.
Source facts
- Action
- Firm issued a Dr. Doctor letter dated 06/17/05. Letter informs physicians of the issue, clinical implications, recommendations and action taken by the firm.
- Initiated
- 2005-06-17
- Root cause
- Other
- Terminated
- 2008-03-02
- Distribution
- worldwide. To the US and OUS countries to include: Argentina, Australia, Austria, Belgium, Canada, Chile, Cyprus, Denmark, France, Germany, Guadeloupe, Hong Kong, Ireland, Israel, Italy, Japan, Jordan, Lebanon, Luxembourg, Netherlands, New Zealand, Norway, Portugal, Saudi Arabia, Slovenia, Spain, Sweden, Switzerland, Syrian Arab Republic, Turkey, US - Virgin Islands and United Kingdom.
- Recall number
- Z-0955-05
- Recall status
- Terminated
- CDRH record ID
- 39951
- FDA classified
- 2005-06-30
- Recall event number
- 32391